MX229299B - Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion - Google Patents
Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacionInfo
- Publication number
- MX229299B MX229299B MXPA01004873A MX229299B MX 229299 B MX229299 B MX 229299B MX PA01004873 A MXPA01004873 A MX PA01004873A MX 229299 B MX229299 B MX 229299B
- Authority
- MX
- Mexico
- Prior art keywords
- mouth
- preparation process
- dose forms
- mixture
- dosage forms
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 abstract 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 abstract 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 230000002460 anti-migrenic effect Effects 0.000 abstract 1
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 1
- 230000001362 anti-vertigo Effects 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940124575 antispasmodic agent Drugs 0.000 abstract 1
- -1 antispasmodics Substances 0.000 abstract 1
- 239000002876 beta blocker Substances 0.000 abstract 1
- 229940097320 beta blocking agent Drugs 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003326 hypnotic agent Substances 0.000 abstract 1
- 230000000147 hypnotic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000003152 motion sickness Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9911513A FR2798289B1 (fr) | 1999-09-15 | 1999-09-15 | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
| FR99/11513 | 1999-09-15 | ||
| PCT/FR2000/002563 WO2001019336A1 (fr) | 1999-09-15 | 2000-09-15 | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA01004873A MXPA01004873A (es) | 2002-06-05 |
| MX229299B true MX229299B (es) | 2005-07-20 |
Family
ID=9549849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA/A/2001/004873 MX229299B (es) | 1999-09-15 | 2000-09-15 | Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6669957B1 (es) |
| EP (1) | EP1131050B8 (es) |
| JP (1) | JP2003509353A (es) |
| KR (1) | KR100854033B1 (es) |
| AT (1) | ATE267581T1 (es) |
| AU (1) | AU7526300A (es) |
| BR (1) | BR0007151A (es) |
| CA (1) | CA2350675A1 (es) |
| DE (1) | DE60011036T2 (es) |
| ES (1) | ES2222234T3 (es) |
| FR (1) | FR2798289B1 (es) |
| HU (1) | HUP0104914A3 (es) |
| MA (1) | MA25323A1 (es) |
| MX (1) | MX229299B (es) |
| PL (1) | PL200672B1 (es) |
| PT (1) | PT1131050E (es) |
| WO (1) | WO2001019336A1 (es) |
| ZA (1) | ZA200103280B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| FI20022007A0 (fi) * | 2002-11-08 | 2002-11-08 | Juvantia Pharma Ltd Oy | Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi |
| GB0226076D0 (en) * | 2002-11-08 | 2002-12-18 | Rp Scherer Technologies Inc | Improved formulations containing substituted imidazole derivatives |
| EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| GB2411355B (en) | 2004-02-27 | 2006-02-22 | Niche Generics Ltd | Pharmaceutical composition |
| US8007827B2 (en) * | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| US20050226927A1 (en) * | 2004-04-02 | 2005-10-13 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist |
| US20050220874A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist |
| US20050220873A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist |
| DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
| TWI338583B (en) * | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
| JP5112619B2 (ja) * | 2004-05-20 | 2013-01-09 | 大塚製薬株式会社 | 固形医薬製剤 |
| DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
| EP1888025B1 (en) * | 2005-06-08 | 2020-08-12 | Basf Corporation | Medicament carrier composition and method of forming a film therefrom |
| EP1942902A1 (en) * | 2005-09-30 | 2008-07-16 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical preparation containing meloxicam |
| US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
| GB2443793B (en) * | 2006-04-05 | 2010-12-01 | Reckitt Benckiser Healthcare | Product, method of manufacture and use |
| BRPI0819824A2 (pt) * | 2007-11-14 | 2014-10-07 | Manuel Gidekel | Novos extratos de deschampsia antartica desv. com atividade antineoplásica |
| US8617588B2 (en) * | 2009-03-09 | 2013-12-31 | Spi Pharma, Inc. | Highly compactable and durable direct compression excipients and excipient systems |
| PL4378443T3 (pl) | 2009-10-12 | 2025-09-08 | Boehringer Ingelheim Vetmedica Gmbh | Pojemniki na kompozycje zawierające meloksykam |
| EP2314296A1 (en) * | 2009-10-22 | 2011-04-27 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally Disintegrating Tablets of Betahistine |
| CA2791805A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| EP4173619A3 (en) * | 2013-11-13 | 2023-07-19 | National Defense Education and Research Foundation | New acetaminophen compound composition without side effect to liver |
| JP6858729B2 (ja) * | 2018-05-25 | 2021-04-14 | ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成 |
| FR3099881B1 (fr) | 2019-08-13 | 2022-08-26 | Ethypharm Sa | Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation. |
| WO2024187116A2 (en) * | 2023-03-08 | 2024-09-12 | Cornell University | Thermophobic trehalose glycopolymers as smart c-type lectin receptor vaccine adjuvants |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH26730A (en) * | 1988-12-30 | 1992-09-28 | Ciba Geigy Ag | Coated adhesive tablets |
| DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| AU1729297A (en) * | 1996-02-09 | 1997-08-28 | Quadrant Holdings Cambridge Limited | Solid formulations containing trehalose |
| AR017512A1 (es) * | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
| US6465009B1 (en) * | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
-
1999
- 1999-09-15 FR FR9911513A patent/FR2798289B1/fr not_active Expired - Fee Related
-
2000
- 2000-09-15 PL PL347693A patent/PL200672B1/pl not_active IP Right Cessation
- 2000-09-15 BR BR0007151-0A patent/BR0007151A/pt not_active Application Discontinuation
- 2000-09-15 DE DE60011036T patent/DE60011036T2/de not_active Expired - Fee Related
- 2000-09-15 US US09/831,711 patent/US6669957B1/en not_active Expired - Fee Related
- 2000-09-15 KR KR1020017005940A patent/KR100854033B1/ko not_active Expired - Fee Related
- 2000-09-15 ES ES00964295T patent/ES2222234T3/es not_active Expired - Lifetime
- 2000-09-15 WO PCT/FR2000/002563 patent/WO2001019336A1/fr not_active Ceased
- 2000-09-15 AU AU75263/00A patent/AU7526300A/en not_active Abandoned
- 2000-09-15 CA CA002350675A patent/CA2350675A1/fr not_active Abandoned
- 2000-09-15 AT AT00964295T patent/ATE267581T1/de not_active IP Right Cessation
- 2000-09-15 MX MXPA/A/2001/004873 patent/MX229299B/es active IP Right Grant
- 2000-09-15 HU HU0104914A patent/HUP0104914A3/hu unknown
- 2000-09-15 EP EP00964295A patent/EP1131050B8/fr not_active Expired - Lifetime
- 2000-09-15 JP JP2001522971A patent/JP2003509353A/ja active Pending
- 2000-09-15 PT PT00964295T patent/PT1131050E/pt unknown
-
2001
- 2001-04-23 ZA ZA200103280A patent/ZA200103280B/en unknown
- 2001-06-04 MA MA26222A patent/MA25323A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1131050A1 (fr) | 2001-09-12 |
| EP1131050B1 (fr) | 2004-05-26 |
| AU7526300A (en) | 2001-04-17 |
| HUP0104914A3 (en) | 2003-05-28 |
| ATE267581T1 (de) | 2004-06-15 |
| PT1131050E (pt) | 2004-11-30 |
| HUP0104914A2 (hu) | 2002-07-29 |
| DE60011036D1 (de) | 2004-07-01 |
| WO2001019336A1 (fr) | 2001-03-22 |
| MA25323A1 (fr) | 2001-12-31 |
| ZA200103280B (en) | 2001-10-25 |
| PL200672B1 (pl) | 2009-01-30 |
| KR20010089883A (ko) | 2001-10-12 |
| EP1131050B8 (fr) | 2004-11-10 |
| BR0007151A (pt) | 2001-08-14 |
| CA2350675A1 (fr) | 2001-03-22 |
| ES2222234T3 (es) | 2005-02-01 |
| PL347693A1 (en) | 2002-04-22 |
| KR100854033B1 (ko) | 2008-08-26 |
| US6669957B1 (en) | 2003-12-30 |
| JP2003509353A (ja) | 2003-03-11 |
| DE60011036T2 (de) | 2005-06-23 |
| FR2798289B1 (fr) | 2004-12-31 |
| FR2798289A1 (fr) | 2001-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX229299B (es) | Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion | |
| MY118371A (en) | Tetrahydrolipstatin containing compositions | |
| CA2102630A1 (en) | Pharmaceutical compositions of compacted medicaments | |
| EP1365749A4 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS | |
| WO2001041770A3 (en) | Nanoparticulate eplerenone compositions | |
| RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
| DE60121570D1 (de) | Oral anzuwendende schnell zerfallende feste darreichungsformen | |
| DE69637961D1 (de) | Verabreichung von biologisch aktiven polypeptiden | |
| ITRM930591A0 (it) | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. | |
| PT1411921E (pt) | Composições farmacêuticas contendo terbinafina e suas utilizações | |
| AR013117A1 (es) | Una composicion farmaceutica solida en forma de comprimido que comprende un derivado de benzofurano con actividad antiarritmica adaptada para administracion oral | |
| ATE232100T1 (de) | Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen | |
| EP0350701A3 (en) | Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes | |
| MY127350A (en) | Flash-melt oral dose formulations | |
| WO2003049694A3 (en) | Methods of therapy for non-hodgkin's lymphoma | |
| BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
| MY136059A (en) | Swallow tablet comprising paracetamol | |
| HUP0104476A2 (hu) | Hidroxi-propil-mutil-cellulóz kapszulákban formázott gyógyszerkészítmények | |
| ES2099021B1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
| MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| PT1144420E (pt) | Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao | |
| PL1499278T3 (pl) | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon | |
| MY145885A (en) | Controlled release formulations for oral administration | |
| ECSP982396A (es) | Composiciones que contienen tetrahidrolipstatina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |